Keratinocyte gene therapy.
Keratinocyte gene therapy.
复制标题
角质形成细胞基因治疗。
DOI:
10.1001/archderm.1993.01680320112015
复制
发表时间:
1993
影响因子:
--
通讯作者:
Jonathan C. Vogel
中科院分区:
文献类型:
--
作者:
Jonathan C. Vogel
BACKGROUND
Gene therapy is currently being used in clinical trials to treat a variety of diseases. In keratinocyte gene therapy, the gene that will correct the disease by expressing the normal protein or enzyme is inserted and expressed in keratinocytes. Keratinocytes have significant potential, as a target cell of gene therapy, in the treatment of both systemic diseases as well as skin diseases caused by a genetic defect in keratinocytes.
OBSERVATIONS
Although keratinocyte gene therapy is not yet being tested in clinical trials, animal models do exist where keratinocytes are being used to secrete factors such as human growth hormone and factor IX (for hemophilia) into the systemic circulation. Genetic diseases of the skin such as recessive epidermolysis bullosa dystrophica or xeroderma pigmentosum have not yet been treated with keratinocyte gene therapy in animal models.
CONCLUSIONS
Keratinocytes have many advantages as a target cell in gene therapy, and progress has been made using animal models. However, the sustained and efficient delivery of factors to the bloodstream by keratinocytes expressing a transgene has not yet been accomplished. Future goals are to obtain adequate levels of the desired factors, hormones, or enzymes for sustained periods of time, either in keratinocytes or in the vascular system.
登录
查看更多内容
DOI:
10.1073/pnas.87.13.5173
发表时间:
1990
影响因子:
11.1
作者:
Axelrod,JH;Read,MS;Brinkhous,KM;Verma,IM
通讯作者:
Verma,IM
影响因子:
10.5
作者:
LEASK, A;ROSENBERG, M;FUCHS, E
通讯作者:
FUCHS, E
DOI:
10.1073/pnas.90.11.5237
发表时间:
1993
影响因子:
11.1
作者:
Sellheyer,K;Bickenbach,JR;Rothnagel,JA;Bundman,D;Longley,MA;Krieg,T;Roche,NS;Roberts,AB;Roop,DR
通讯作者:
Roop,DR
影响因子:
4.2
作者:
Ramesh,N;Lau,S;Palmer,TD;Storb,R;Osborne,WR
通讯作者:
Osborne,WR
影响因子:
20.3
作者:
Palmer,TD;Thompson,AR;Miller,AD
通讯作者:
Miller,AD